{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:19:33Z","timestamp":1792671573704,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijrobp.2025.03.056","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:26:55Z","timestamp":1743748015000},"page":"204-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-3694","authenticated-orcid":false,"suffix":"II","given":"Charles B.","family":"Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrin J.","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Isabelle","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Donington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry L.","family":"Kestin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranshu","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Movsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor I.","family":"Rybkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie F.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.056_bib0001","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0003","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: A phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0006","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.adro.2017.07.009","article-title":"Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (\u226560 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer","volume":"2","author":"Vyfhuis","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0007","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0008","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1378\/chest.12-2580","article-title":"Stereotactic body radiation therapy for lung cancer","volume":"143","author":"Simone","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0009","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0011","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","article-title":"Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma","volume":"7","author":"Machtay","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0012","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/01243894-200611000-00021","article-title":"Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: A systematic review and practice guideline","volume":"1","author":"Noble","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0013","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2022.03.034","article-title":"Retreatment of recurrent or second primary head and neck cancer after prior radiation: Executive summary of the American Radium Society Appropriate Use Criteria","volume":"113","author":"Ward","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2016.10.001","article-title":"National cancer database analysis of proton versus photon radiation therapy in non-small cell lung cancer","volume":"97","author":"Higgins","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0019","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-8-99","article-title":"Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)","volume":"8","author":"Reyngold","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13566-014-0175-2","article-title":"Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses","volume":"4","author":"Patel","year":"2015","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0023","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.prro.2017.11.011","article-title":"Thoracic reirradiation with SBRT for residual\/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field","volume":"8","author":"Horne","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0024","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2012.02.020","article-title":"Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy","volume":"84","author":"Liu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","article-title":"Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment","volume":"110","author":"Kilburn","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0026","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-019-5542-3","article-title":"Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer","volume":"19","author":"Sumodhee","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0027","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2011.09.012","article-title":"Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy","volume":"101","author":"Peulen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0028","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2019.08.010","article-title":"Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT","volume":"142","author":"Kennedy","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0029","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4103\/0973-1482.126481","article-title":"Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site","volume":"9","author":"Valakh","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijrobp.2014.05.048","article-title":"Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT","volume":"90","author":"Hearn","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0031","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0360-3016(03)00768-5","article-title":"Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: A prospective phase I-II clinical trial","volume":"57","author":"Wu","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtho.2016.10.018","article-title":"Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer","volume":"12","author":"Chao","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0033","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.prro.2019.02.008","article-title":"Clinical outcomes of patients with recurrent lung cancer reirradiated with proton therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies","volume":"9","author":"Badiyan","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0034","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2013.08.014","article-title":"Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer","volume":"109","author":"McAvoy","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0035","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2014.07.030","article-title":"Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: Predictors of high-grade toxicity and survival outcomes","volume":"90","author":"McAvoy","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0036","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.prro.2017.07.002","article-title":"Reirradiation of thoracic cancers with intensity modulated proton therapy","volume":"8","author":"Ho","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0037","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lungcan.2015.02.008","article-title":"High-dose conventional thoracic re-irradiation for lung cancer: Updated results","volume":"88","author":"Tetar","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0038","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.lungcan.2013.12.006","article-title":"High-dose, conventionally fractionated thoracic reirradiation for lung tumors","volume":"83","author":"Griffioen","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0039","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ijrobp.2015.12.007","article-title":"Dosimetric factors and toxicity in highly conformal thoracic reirradiation","volume":"94","author":"Binkley","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0040","first-page":"5649","article-title":"Definitive fractionated re-irradiation for local recurrence following stereotactic body radiotherapy for primary lung cancer","volume":"33","author":"Yoshitake","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0041","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4143\/crt.2018.472","article-title":"High-dose thoracic re-irradiation of lung cancer using highly conformal radiotherapy is effective with acceptable toxicity","volume":"51","author":"Hong","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0042","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-018-1016-z","article-title":"The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation","volume":"13","author":"Ren","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0043","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/cancers9090120","article-title":"Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer","volume":"9","author":"Verma","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0044","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","article-title":"High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer","volume":"15","author":"De Ruysscher","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2013.02.002","article-title":"Aortic dose constraints when reirradiating thoracic tumors","volume":"106","author":"Evans","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0046","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2013.03.015","article-title":"Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity","volume":"107","author":"Meijneke","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0047","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.semradonc.2020.02.008","article-title":"The medical physics management of reirradiation patients","volume":"30","author":"Paradis","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0048","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1200\/JCO.2016.71.5581","article-title":"New era in radiation oncology for lung cancer: Recognizing the importance of cardiac irradiation","volume":"35","author":"Simone","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0049","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semradonc.2017.04.009","article-title":"Thoracic radiation normal tissue injury","volume":"27","author":"Simone","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0050","doi-asserted-by":"crossref","first-page":"S2522","DOI":"10.21037\/jtd.2017.12.50","article-title":"Reirradiation for locoregionally recurrent non-small cell lung cancer","volume":"10","author":"Vyfhuis","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0051","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10147-005-0501-1","article-title":"Non-small-cell lung cancer: Reirradiation for loco-regional relapse previously treated with radiation therapy","volume":"10","author":"Tada","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0052","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0360-3016(01)02644-X","article-title":"Reirradiation for locally recurrent lung cancer previously treated with radiation therapy","volume":"52","author":"Okamoto","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0053","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/1097-0142(19820301)49:5<865::AID-CNCR2820490507>3.0.CO;2-H","article-title":"Lung cancer: Retreatment of local recurrence after definitive irradiation","volume":"49","author":"Green","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0054","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00000421-199312000-00004","article-title":"The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation","volume":"16","author":"Montebello","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/tlcr.2018.09.25","article-title":"Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy","volume":"8","author":"Molitoris","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0056","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13014-014-0278-3","article-title":"Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent\/unresectable rectal cancer in patients with previous pelvic irradiation: Results of a phase II study","volume":"9","author":"Cai","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0057","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2016.12.015","article-title":"Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity","volume":"122","author":"Tao","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0058","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.adro.2016.02.002","article-title":"Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy","volume":"1","author":"Youssef","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0059","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2018.05.005","article-title":"Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab","volume":"128","author":"Tao","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2016.01.036","article-title":"Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer","volume":"95","author":"Chang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0061","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PPO.0000000000000080","article-title":"The use of proton therapy in the treatment of lung cancers","volume":"20","author":"Simone","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0062","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190879","article-title":"Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study","volume":"93","author":"Troost","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0063","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semradonc.2020.02.001","article-title":"Challenges in re-irradiation in the thorax: Managing patients with locally recurrent non-small cell lung cancer","volume":"30","author":"Fischer-Valuck","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0064","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","article-title":"Proton reirradiation: Expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies","volume":"30","author":"Simone","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","article-title":"Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee","volume":"99","author":"Chang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0066","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1120\/jacmp.v16i6.5678","article-title":"Beam-specific planning target volumes incorporating 4D CT for pencil beam scanning proton therapy of thoracic tumors","volume":"16","author":"Lin","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0067","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/0284186X.2017.1293287","article-title":"A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer","volume":"56","author":"Kang","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0068","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2014.07.045","article-title":"Clinical implementation of intensity modulated proton therapy for thoracic malignancies","volume":"90","author":"Chang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0069","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cllc.2014.12.001","article-title":"Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: A dosimetric study","volume":"16","author":"Kesarwala","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2009.04.028","volume":"77","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0071","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijrobp.2010.03.012","article-title":"Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer","volume":"80","author":"Register","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0072","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fonc.2017.00201","article-title":"The potential of heavy-ion therapy to improve outcomes for locally advanced non-small cell lung cancer","volume":"7","author":"Chun","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0073","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/cas.13555","article-title":"Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumors","volume":"109","author":"Hayashi","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0074","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2017.08.005","article-title":"Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation","volume":"125","author":"Verma","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2016.01.055","article-title":"First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer","volume":"95","author":"Veiga","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0076","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lungcan.2020.12.025","article-title":"Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives","volume":"152","author":"Lazarev","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0077","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0078","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2023.08.047","article-title":"Phase 2 trial of consolidation pembrolizumab after proton reirradiation for thoracic recurrences of non-small cell lung cancer","volume":"119","author":"Yegya-Raman","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0079","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13014-021-01977-1","article-title":"An algorithm for thoracic re-irradiation using biologically effective dose: A common language on how to treat in a \u201cno-treat zone","volume":"17","author":"Brooks","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0080","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1120\/jacmp.v15i3.4661","article-title":"Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers","volume":"15","author":"Kang","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0081","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1088\/0031-9155\/58\/22\/8179","article-title":"Investigation of pulsed IMRT and VMAT for re-irradiation treatments: Dosimetric and delivery feasibilities","volume":"58","author":"Lin","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0082","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1118\/1.4735471","article-title":"Ma C. SU-E-T-383: Pulsed low dose rate radiotherapy using advanced treatment methods: A novel technique for patient re-irradiation","volume":"39","author":"Lin","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0083","doi-asserted-by":"crossref","first-page":"245ra93","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0084","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1667\/RADE-20-FLASH.1","article-title":"Radiation research special issue: New beam delivery modalities are shaping the future of radiotherapy","volume":"194","author":"Griffin","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0085","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.3390\/cancers13143549","article-title":"Quantitative assessment of 3D dose rate for proton pencil beam scanning FLASH radiotherapy and its application for lung hypofractionation treatment planning","volume":"13","author":"Kang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0086","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.3390\/cancers13225790","article-title":"A novel proton pencil beam scanning FLASH RT delivery method enables optimal OAR sparing and ultra-high dose rate delivery: A comprehensive dosimetry study for lung tumors","volume":"13","author":"Wei","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0087","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.970602","article-title":"Dose rate and dose robustness for proton transmission FLASH-RT treatment in lung cancer","volume":"12","author":"Wei","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.056_bib0088","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-024-02419-4","article-title":"FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): Protocol for a prospective study of a novel radiotherapy approach","volume":"19","author":"Daugherty","year":"2024","journal-title":"Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:31:19Z","timestamp":1777955479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0360301625002597"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.056","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}